Fed. Circ. Shouldn't Assume Doctors Read Labels, Profs Say <https://www.law360.com/health/articles/2301525?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-02-25&read_main=1&nlsidx=0&nlaidx=3>
By Dani Kass The Federal Circuit has been reviewing whether generic-drug companies induce infringement of their limited-use drugs based on a misunderstanding of how prescribing physicians do their job, law professors from Illinois and Pennsylvania have argued in a new paper. 1 document attached | Read full article » <https://www.law360.com/health/articles/2301525?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-02-25&read_more=1&nlsidx=0&nlaidx=3> | Save to favorites » <https://www.law360.com/health/articles/2301525?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-02-25&read_later=1&nlsidx=0&nlaidx=3>
